ArticleThe Journal of clinical investigation2019

Deubiquitinating ALDH1A3 key to maintaining the culprit of aggressive brain cancer.

Hiroaki WakimotoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.